| Q35164876 | Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges |
| Q78073575 | Current literature in. Pharmacoepidemiology and drug safety |
| Q36745170 | Dietary supplements in patients with cancer: risks and key concepts, part 2. |
| Q57179831 | Drug Interactions with St. John's Wort |
| Q35593896 | Drug interactions between herbal and prescription medicines. |
| Q35879020 | Drug interactions with St John's wort : mechanisms and clinical implications |
| Q44697441 | Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers |
| Q35009679 | Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations |
| Q36014951 | Herb-drug interactions: an overview of the clinical evidence |
| Q80058660 | Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol |
| Q33498604 | Interactions between herbal medicines and prescribed drugs: an updated systematic review |
| Q34124444 | Interactions between herbs and conventional drugs: overview of the clinical data. |